NightHawk Biosciences, Inc.
USD0.41
+0.03 (+8.96%)
CEO
Jeffrey Alan Wolf
IPO Date
2013-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$0.37
Prev. Close
$0.38
Day Low
$0.37
Day High
$0.43
52W Low
$0.26
52W High
$1.03
Market Cap
$0.01B
Volume
0.16M
| 2,843,137 |
| $0.00 |
| 9 Dec 2022 | PRENDERGAST JOHN K A | director | A-Award | Acquired | 203,921 | $0.00 |
| 9 Dec 2022 | Ostrander William L. | CFO/Corp Secy | A-Award | Acquired | 490,196 | $0.00 |
| 9 Dec 2022 | Smith Edward B III | director | A-Award | Acquired | 101,960 | $0.00 |
| 3 Jan 2022 | MONAHAN JOHN J | director | A-Award | Acquired | 32,467 | $4.06 |
| 3 Jan 2022 | MONAHAN JOHN J | director | J-Other | Disposed | 32,467 | $4.06 |
| 3 Jan 2022 | Wolf Jeffrey Alan | director, officer: Chief Executive Officer | A-Award | Acquired | 231,987 | $4.07 |
| 3 Jan 2022 | Wolf Jeffrey Alan | director, officer: Chief Executive Officer | J-Other | Disposed | 231,987 | $4.07 |
| 3 Jan 2022 | PRENDERGAST JOHN K A | director | A-Award | Acquired | 129,820 | $4.06 |